[
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The evaluation of large tumor areas with high-throughput, whole tissue section imaging methods, such as CyCIF (227) (\nFigure 1\n), and in the future, 3D modeling of tumor architecture will provide a deeper knowledge of potential novel biomarkers and therapeutic targets in HR+ breast cancer.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  }
]